Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
923 trades
$2B in total
Open-market sales
1,038 trades
$2.3B in total
Insiders filing
464 insiders
Last 7 days
Trade type
Director
CVS HealthCVS
Open-market sale05/19–05/2105/213,372,000 sh7 trades$94.15avg.$317,479,376.65−41.1%
Tilak MandadiEVP, Chief Exp & Tech Officer
CVS HealthCVS
Open-market sale05/0805/1169,551 sh$89.58$6,230,378.58−87.3%
Steven H. NelsonEVP and President, Aetna
CVS HealthCVS
Open-market buy25/01/2301/2724 sh$53.70$1,288.8No record
EVP and Chief People Officer
CVS HealthCVS
Open-market buy24/09/09–24/10/2325/10/1480 sh3 trades$57.36avg.$4,588.6+1600.0%
CVS HealthCVS
Open-market sale25/08/2025/08/297,500 sh$71.02$532,650−25.3%
CVS HealthCVS
Open-market buy25/06/0525/06/091,570 sh$63.70$100,009+15.0%
Director
CVS HealthCVS
Open-market sale25/05/02–25/05/0625/05/063,750,000 sh6 trades$67.66avg.$253,706,962.7−31.4%
Clark James DavidSVP, Cont & Chief Acct Officer
CVS HealthCVS
Open-market sale25/03/0525/03/077,513 sh$66.35$498,487.55−47.2%
CVS HealthCVS
Open-market buy25/02/1825/02/1930,000 sh$66.70$2,001,000+320.6%
CVS HealthCVS
Open-market buy24/05/0224/05/021,000 sh$53.88$53,880+4.8%
CVS HealthCVS
Open-market buy24/05/0224/05/029,181 sh$54.49$500,272.69+5246.3%
Prem S. ShahEVP and Pres-Pharm, Consumer W
CVS HealthCVS
Open-market sale24/02/1624/02/1629,473 sh$76.95$2,267,947.35−42.6%
CVS HealthCVS
Open-market buy23/11/0323/11/062,000 sh$70.47$140,940+10.7%
SVP, Cont & Chief Acct Officer
CVS HealthCVS
Open-market sale23/08/0323/08/0425,759.26 sh2 trades$74.92avg.$1,930,004.26−84.6%
Karen S. LynchPresident and CEO
CVS HealthCVS
Open-market buy23/05/0323/05/0514,000 sh$69.75$976,500+3.4%